Minich Mac Gregor Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Minich Mac Gregor Wealth Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$680.49 - $826.97 $306,220 - $372,136	450 Added 608.11%	524 $430,000
Q4 2022 Jan 09, 2023	BUY	$705.89 - $766.39 $52,235 - $56,712	74 New	74 $0
Q4 2018 Jan 17, 2019	SELL	$335.82 - $403.04 $15,783 - $18,942	-47 Closed	0 $0
Q3 2018 Oct 17, 2018	SELL	$351.14 - $408.51 $7,373 - $8,578	-21 Reduced 30.88%	47 $18,000
Q2 2018 Jul 13, 2018	SELL	$284.6 - $344.99 $21,060 - $25,529	-74 Reduced 52.11%	68 $23,000
Q1 2018 Jul 03, 2018	SELL	$315.82 - $393.78 $631 - $787	-2 Reduced 1.39%	142 $48,000
Q4 2017 Jul 03, 2018	BUY	$358.63 - $469.95 $2,510 - $3,289	7 Added 5.11%	144 $54,000
Q3 2017 Jul 03, 2018	BUY	$431.38 - $504.0 $30,627 - $35,784	71 Added 107.58%	137 $61,000
Q2 2017 Jul 02, 2018	SELL	N/A	-63 Reduced 48.84%	66 $32,000
Q1 2017 Jun 28, 2018	SELL	N/A	-2 Reduced 1.53%	129 $49,000
Q4 2016 Jun 28, 2018	SELL	N/A	-35 Reduced 21.08%	131 $48,000
Q3 2016 Jun 28, 2018	SELL	N/A	-1 Reduced 0.6%	166 $66,000
Q1 2016 Jun 28, 2018	BUY	N/A	167	167 $60,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Minich Mac Gregor Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Minich Mac Gregor Wealth Management, LLC with notifications on news.